These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38715339)

  • 1. Reproducibility and reliability of pancreatic pharmacokinetic parameters derived from dynamic contrast-enhanced magnetic resonance imaging.
    Zhao W; Liu C; Huan Y; Bi Y; Zhu Y; Zhang W; Wang S; Yang Y; Quan Z
    Acta Radiol; 2024 Jul; 65(7):681-688. PubMed ID: 38715339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
    Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
    Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
    Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
    J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra- and inter-observer variability in dependence of T1-time correction for common dynamic contrast enhanced MRI parameters in prostate cancer patients.
    Daniel M; Polanec SH; Wengert G; Clauser P; Pinker K; Helbich TH; Georg D; Baltzer PAT
    Eur J Radiol; 2019 Jul; 116():27-33. PubMed ID: 31153570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative pharmacokinetic analysis of high-temporal-resolution dynamic contrast-enhanced MRI to differentiate the normal-appearing pituitary gland from pituitary macroadenoma.
    Kamimura K; Nakajo M; Yoneyama T; Bohara M; Nakanosono R; Fujio S; Iwanaga T; Nickel MD; Imai H; Fukukura Y; Yoshiura T
    Jpn J Radiol; 2020 Jul; 38(7):649-657. PubMed ID: 32162178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
    Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
    BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor segmentation analysis at different post-contrast time points: A possible source of variability of quantitative DCE-MRI parameters in locally advanced breast cancer.
    Romeo V; Cavaliere C; Imbriaco M; Verde F; Petretta M; Franzese M; Stanzione A; Cuocolo R; Aiello M; Basso L; Amitrano M; Lauria R; Accurso A; Brunetti A; Salvatore M
    Eur J Radiol; 2020 May; 126():108907. PubMed ID: 32145597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion-sensitive parameters of intravoxel incoherent motion MRI in rectal cancer: evaluation of reproducibility and correlation with dynamic contrast-enhanced MRI.
    Yang X; Xiao X; Lu B; Chen Y; Wen Z; Yu S
    Acta Radiol; 2019 May; 60(5):569-577. PubMed ID: 30114928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of Dynamic Contrast-Enhanced MRI in Renal Cell Carcinoma: A Prospective Analysis on Intra- and Interobserver and Scan-Rescan Performance of Pharmacokinetic Parameters.
    Wang H; Su Z; Ye H; Xu X; Sun Z; Li L; Duan F; Song Y; Lambrou T; Ma L
    Medicine (Baltimore); 2015 Sep; 94(37):e1529. PubMed ID: 26376399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Contrast-enhanced MR Imaging in Renal Cell Carcinoma: Reproducibility of Histogram Analysis on Pharmacokinetic Parameters.
    Wang HY; Su ZH; Xu X; Sun ZP; Duan FX; Song YY; Li L; Wang YW; Ma X; Guo AT; Ma L; Ye HY
    Sci Rep; 2016 Jul; 6():29146. PubMed ID: 27380733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative dynamic contrast-enhanced MR imaging for the preliminary prediction of the response to gemcitabine-based chemotherapy in advanced pancreatic ductal carcinoma.
    Tang W; Liu W; Li HM; Wang QF; Fu CX; Wang XH; Zhou LP; Peng WJ
    Eur J Radiol; 2019 Dec; 121():108734. PubMed ID: 31743881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Arterial Input Function and Pharmacokinetic Models on DCE-MRI Biomarkers for Detection of Vascular Effect Induced by Stroma-Directed Drug in an Orthotopic Mouse Model of Pancreatic Cancer.
    Cao J; Pickup S; Rosen M; Zhou R
    Mol Imaging Biol; 2023 Aug; 25(4):638-647. PubMed ID: 37166575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced MRI: Study of inter-software accuracy and reproducibility using simulated and clinical data.
    Beuzit L; Eliat PA; Brun V; Ferré JC; Gandon Y; Bannier E; Saint-Jalmes H
    J Magn Reson Imaging; 2016 Jun; 43(6):1288-300. PubMed ID: 26687041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton.
    Lang N; Su MY; Xing X; Yu HJ; Yuan H
    J Magn Reson Imaging; 2017 Apr; 45(4):1068-1075. PubMed ID: 27490009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced MRI in orbital lymphoproliferative disorders: Effects of region of interest selection methods on time efficiency, measurement reproducibility, and diagnostic ability.
    Qian W; Xu XQ; Hu H; Su GY; Wu JF; Shi HB; Wu FY
    J Magn Reson Imaging; 2018 May; 47(5):1298-1305. PubMed ID: 28922524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.
    Lang N; Yuan H; Yu HJ; Su MY
    Acad Radiol; 2017 Jul; 24(7):867-875. PubMed ID: 28162875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of artery input function on dynamic contrast-enhanced MRI for determining grades of gliomas.
    Jia L; Wu X; Wan Q; Wan L; Jia W; Zhang N
    Br J Radiol; 2021 Mar; 94(1119):20200699. PubMed ID: 33332981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of endometrial adenocarcinoma from adenocarcinoma of cervix using kinetic parameters derived from DCE-MRI.
    Lin M; Zhang Q; Song Y; Yu X; Ouyang H; Xie L; Shang Y
    Eur J Radiol; 2020 Sep; 130():109190. PubMed ID: 32745897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.